Crespo J - Search Results

1

Resistance to hepatitis C virus. Implications and therapeutic options.

Llerena S, Cabezas J, Iruzubieta P, Crespo J. Llerena S, et al. Among authors: crespo j. Gastroenterol Hepatol. 2017 Aug-Sep;40(7):484-494. doi: 10.1016/j.gastrohep.2017.04.007. Epub 2017 Jun 22. Gastroenterol Hepatol. 2017. PMID: 28647053 English, Spanish.

2

[Treatment of fatty liver disease].

Cobo Martín M, Fernández Gil P, Crespo J. Cobo Martín M, et al. Among authors: crespo j. Gastroenterol Hepatol. 2008 Apr;31(4):229-38. doi: 10.1157/13117902. Gastroenterol Hepatol. 2008. PMID: 18405489 Review. Spanish.

3

Chemoprophylaxis with isoniazid in liver transplant recipients.

Fábrega E, Sampedro B, Cabezas J, Casafont F, Mieses MÁ, Moraleja I, Crespo J, Pons-Romero F. Fábrega E, et al. Among authors: crespo j. Liver Transpl. 2012 Sep;18(9):1110-7. doi: 10.1002/lt.23480. Liver Transpl. 2012. PMID: 22645064 Free article.

4

[Telaprevir in treatment-naïve patients with HCV monoinfection].

Cabezas J, Crespo J, Selmo J, Luis Calleja J. Cabezas J, et al. Among authors: crespo j. Enferm Infecc Microbiol Clin. 2013 Jul;31 Suppl 3:7-13. doi: 10.1016/S0213-005X(13)70118-6. Enferm Infecc Microbiol Clin. 2013. PMID: 24063897 Review. Spanish.

5

Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain.

Turnes J, Romero-Gómez M, Planas R, Solà R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Rubio-Terrés C, Ventayol P. Turnes J, et al. Among authors: crespo j. Gastroenterol Hepatol. 2013 Nov;36(9):555-64. doi: 10.1016/j.gastrohep.2013.08.003. Epub 2013 Oct 9. Gastroenterol Hepatol. 2013. PMID: 24119723

6

Long-term survival after liver transplantation for alcoholic liver disease.

Iruzubieta P, Crespo J, Fábrega E. Iruzubieta P, et al. Among authors: crespo j. World J Gastroenterol. 2013 Dec 28;19(48):9198-208. doi: 10.3748/wjg.v19.i48.9198. World J Gastroenterol. 2013. PMID: 24409048 Free PMC article. Review.

7

Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project.

Sampedro B, Hernández-López C, Ferrandiz JR, Illaro A, Fábrega E, Cuadrado A, Iruzubieta P, Menéndez S, Cabezas J, Crespo J. Sampedro B, et al. Among authors: crespo j. Hepatology. 2014 Jul;60(1):106-13. doi: 10.1002/hep.27103. Epub 2014 May 28. Hepatology. 2014. PMID: 24585503

8

Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.

Crespo J, Cabezas J, Sacristán B, Olcoz JL, Pérez R, De la Vega J, García R, García-Pajares F, Sáez-Royuela F, González JM, Jiménez F, Rodríguez S, Cuadrado A, López-Arias MJ, García I, Milla A, García-Riesco E, Muñoz M, Sánchez-Antolín G, Jorquera F. Crespo J, et al. Liver Int. 2015 Feb;35(2):401-8. doi: 10.1111/liv.12536. Epub 2014 Apr 9. Liver Int. 2015. PMID: 24650000

9

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis.

Londoño MC, Perelló C, Cabezas J, Cañete N, Lens S, Mariño Z, Gambato M, Rodríguez R, Menéndez S, Carrión JA, Crespo J, Calleja JL, Forns X. Londoño MC, et al. Among authors: crespo j. J Hepatol. 2015 Feb;62(2):311-6. doi: 10.1016/j.jhep.2014.09.025. Epub 2014 Oct 2. J Hepatol. 2015. PMID: 25281861

10

Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.

Crespo J, Cabezas J. Crespo J, et al. Liver Int. 2015 Jun;35(6):1775. doi: 10.1111/liv.12752. Epub 2015 Jan 21. Liver Int. 2015. PMID: 25444460 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,012 results

Search Page